The Italian blood system: an overview with special focus on plasma production and plasma-derived medicinal products
|
|
- Marcia Pope
- 6 years ago
- Views:
Transcription
1 The Italian blood system: an overview with special focus on plasma production and plasma-derived medicinal products Giuliano Grazzini National Blood Centre Istituto Superiore di Sanità Rome, Italy
2 The Italian National Health Service basics In Italy, health-care service delivery is delegated to 21 regional health authorities funded by the national healthcare fund (~109 billion in 2013), mainly derived from general fiscal revenues. The governance of the NHS is entirely public (accredited private health-care providers can integrate the public services, according to regional plans). The Ministry of Health is responsible for national coordination, legislation/regulation and control of the appropriate delivery of the health-care services that must be guaranteed homogeneously and equitably nationwide by the regional health authorities.
3 THE ITALIAN BLOOD SYSTEM According to 21 st October 2005 Law New discipline for blood transfusion activities and national production of plasma-derived medicinal products
4 The Italian Blood System: strategic goals I Law 21 October 2005, n. 219 Self-sufficiency of blood and blood products, including plasma-derived medicinal products, as a supra-local and supra-regional goal of the NHS. Promotion and continuous development of voluntary non-remunerated (VNR), regular / repeat blood donation, and VNR donor retention. High quality and safety of blood components, transfusion medicine activities and plasma-derived medicinal products.
5 The Italian Blood System: strategic goals II Law 21 October 2005, n. 219 Achievement of full compliance with European regulatory provisions on blood and blood products Appropriate management and clinical utilization of blood resources (including patient blood management - PBM) Continuous development of transfusion medicine, aligned with scientific progress System s accountability, effectiveness, sustainability
6 The Italian Blood System: essential figures (2013) - I Donors: 1,734,669 / 1,000 pop: 29.1 Male: 69.4% Female: 30.6% Repeat: 1,442,715 (83%) First-time: 291,954 (17%) Frequent *: 682,512 (47,3% of repeat donors) Donations: 3,144,724 / 1,000 pop: 52.9 Whole blood (84%): 2,633,175 / 1,000 pop: 44,3 Apheresis (16%): 511,549 [Plasmapheresis: 409,363] / 1,000 pop: 8.6 Donations / donor / year : 1.81 Apheresis donors: 237,774 (13.7% of total) Apheresis-only donors: 134,371 (56.5% of apheresis donors) * National definition: donating at least once a year, every year, in the last 5 years
7 The Italian Blood System: essential figures (2013) - II Blood components produced Red blood cells (units): 2,625,608 Units / 1,000 pop: 44.0 (30% leukodepleted) Platelets (units*): 271,468 Units / 1,000 pop: 4.5 (30% apheresis) Plasma (units**): 3,107,848 Units / 1,000 pop: 52.1 [plasma for fractionation: 784,000 kg] Others (including by-products): 1,206,148 Total: 7,211,072 * Adult therapeutic dose ** Recovered and apheresis Blood components transfused Red blood cells (units): 2,482,473 Units / 1,000 pop: 41.6 (32,4% leukodepleted) Platelets (units*): 213,689 Units / 1,000 pop: 3.6 (33.4% apheresis) 2,625,608 FFP (units**): 375,268 Units / 1,000 pop: 6.3 (94,313 pharmaceutical pathogen-inactivated ) Total: 3,117,342 Units / 1,000 pop: ,541 blood components transfused / day * Adult therapeutic dose ** Recovered and apheresis Transfused patients 643,616 / year 1,763 patients / day 11 persons / 1,000 pop / year Average number blood components transfused per patient: 4.8
8 Blood & blood product self-sufficiency in Italy - 1 According to the New discipline of blood transfusion activities and national production of plasma-derived medicines (Law of 21 October 2005, n. 219, article 14), every year a national self-sufficiency program must be issued by a decree of the Minister of Health. Annual technical proposals for this program must be provided for by the National Blood Centre after consultation with the relevant stakeholders (Regional Blood Centres and Blood Donor Associations). The annual self-sufficiency program includes prescriptions, recommendations and objectives both on blood and blood product demand and use and on blood and blood component collection and plasma for fractionation production. Since 2008, six annual self-sufficiency programs have been issued.
9 Blood & blood product self-sufficiency in Italy - 2 Driving products for self-sufficiency: red blood cells and plasma for fractionation Driving actions/goals: - recruitment of new donors to ensure donor base turn over - Achievement of full compliance with EU blood regulations and Plasma Master File in 100% BEs (deadline: 31 Dec 2014) - continuous promotion of optimal use of blood - Patient Blood Management national project just launched Monitoring (KPIs)
10 Blood & blood product self-sufficiency in Italy - 3 Blood components for transfusion Nineteen out of 21 regions are fully self-sufficient in Red Blood Cells (RBC) for transfusion The two non self-sufficient regions (11 million pop) are supported by additional RBC production (80,000 units/year) annually planned by self-sufficient regions All regions are self-sufficient for all other blood components for transfusion
11 Blood & blood product self-sufficiency in Italy - 4 Plasma form fractionation (PfF) and PDMPs PDMP production from domestic plasma is by law a national essential health-care service; exchange of products among regions is performed, supported by specific plans and nonprofit/cost-recovery national tariffs PDMPs produced by domestic plasma: polyvalent IVIG, albumin, FVIII, FIX, antithrombin, prothrombin complex, anti-hbv IG Driving products: IVIG, albumin Gaps: most of the central and northern regions have achieved, or are close to achieving, substantial PDMP selfsufficiency, while most south-central and southern regions and the greater islands furthest from self-sufficiency
12 Italy Plasma for fractionation: north vs. south gap POPULATION/TOT: 44% Plasma for fractionation: 27% POPULATION/TOT: 56% Plasma for fractionation: 73% Italy 13.1 L / 1,000 pop: 16 L / 1,000 pop: 9
13 Blood & blood product self-sufficiency in Italy - 5 Plasma form fractionation (PfF) and PDMPs Production of PfF since 2000 Italy - Plasma for fractionation (Kg) Kg plasma Forecast
14 Blood & blood product self-sufficiency in Italy - 6 Plasma form fractionation (PfF) and PDMPs Plasma derived products market (M ) in Europe Top 5 (DE + FR + IT + ES + UK) = 76% 1 DRAFT European Commission An EU-wide overview of the market of blood, blood components and plasma derivatives focusing on their availability for patients
15 Achievements in the field of plasma & PDMPs Analysis of the demand for the main plasma-derived medicinal products in Italy Calizzani G, Lanzoni M, Candura F, Profili S, Catalano L, Vaglio S, Biffoli C, Grazzini G December Report forthcoming!
16 Perspectives of plasma manufacturing in Italy The Italian blood system: an overview with special focus on plasma production and plasma-derived medicinal products Italy - IVIG and albumin demand, IGIV: national demand (Kg) Albumin: national demand (Kg) Percentage of total NHS demand covered by contract fractionation: 71% (2,518 kg) Estimated economic equivalent of contract fractionation IVIG (based on average tender costs of commercial products): 133,380, Percentage of total NHS demand covered by contract fractionation: 54% (16,690 kg) Estimated economic equivalent of contract fractionation albumin (based on average tender costs of commercial products): 49,485,844. CNS elaboration based on Traccia farmaco ( drug tracking ) data provided by Ministry of Health s Directorate General for IT systems and statistics
17 The Italian blood system: an overview Perspectives with special of plasma focus on manufacturing plasma production in Italy and plasma-derived medicinal products Albumin demand Calizzani G, et Al. Analisi della domanda dei principali medicinali plasmaderivati in Italia Rapporti ISTISAN, 12/53.
18 Achievements in the field of plasma & PDMPs Plasma-derived medicinal products: demand and clinical use Guest editors Giuliano Grazzini & Pier Mannuccio Mannucci September
19 Perspectives of plasma manufacturing in Italy The Italian blood system: an overview with special focus on plasma production and plasma-derived medicinal products The estimated economic value of PDMPs produced from national plasma What is the (approximate) economic value of the PDMPs produced in Italy from national plasma? 248,000, estimate (based on average tender costs of commercial products)
20 Perspectives of plasma manufacturing in Italy
21 Perspectives of plasma manufacturing in Italy Provided standardized costs are achieved, Italy could compete with the international commercial market only for recovered plasma Current standardized costs of apheresis plasma are > 2.5 times higher than international commercial prices In spite of the high costs of apheresis plasma, the overall PDMP production from national plasma (with 25% of apheresis plasma) would allow a cost saving around 4-10% compared to current commercial costs of equivalent products.
22 Perspectives of plasma manufacturing in Italy
23 Thanks for your attention! Giuliano Grazzini National Blood Centre Istituto Superiore di Sanità Rome, Italy
KEDRION the fourth pillar for the Italian Blood System
KEDRION the fourth pillar for the Italian Blood System Danilo Medica Italy Country Manager FACTS 15 COLLECTION CENTERS 2 WORLDWIDE PRESENCE 3 BUSINESS AREAS 4 23 MEDICINAL PRODUCTS IN 3 LINES Hemolytic
More informationPlasma donation: Collection volumes and donor safety
Plasma donation: Collection volumes and donor safety G. Cambié SIMT A.S.S.T. Lodi Rome, June 15 th 2018 Plasma national needs (tons) Self sufficiency? 2020 550-600 300 2015 600 Recovered plasma 200 Source
More informationSelf sufficiency program
KEDRION contribution on Self sufficiency program Andrea Benassi KEDRION WORLDWIDE PRESENCE Melville (NY US) Gödollo (Budapest Hu) Bolognana (Lucca) S. Antimo (Naples) Self sufficiency program Support plasma
More informationDONOR RECRUITMENT AND PLASMA COLLECTION IN INDONESIA. Yuyun SM Soedarmono Blood Services Committee Ministry of Health of Indonesia 1
DONOR RECRUITMENT AND PLASMA COLLECTION IN INDONESIA Yuyun SM Soedarmono Blood Services Committee Ministry of Health of Indonesia 1 OUTLINE Introduction Challenges to Fulfill Global Demand of Plasma for
More informationPerspectives on self-sufficiency of blood-derived therapies. Global evolution and realities. Albert Farrugia
TERZO INCONTRO NAZIONALE DEL SISTEMA SANGUE ITALIANO I confini dell autosufficienza. Etica, economia, responsabilità. Perspectives on self-sufficiency of blood-derived therapies. Global evolution and realities.
More informationDatabase on Blood Safety 2009 in ECO Member States
Database on Blood Safety 2009 in ECO Member States Section 1: Administrative Information Information provided by: 1.1 Name: 1.2 Title: 1.3 Position: 1.4 Organization: 1.5 Address: 1.6 Country: 1.7 Tel.
More informationWNV surveillance and prevention of transfusion transmission in Italy
Ministero del Lavoro, della Salute e delle Politiche Sociali Istituto Superiore di Sanità Centro Nazionale Sangue Via Giano della Bella, 27 00162 Roma Tel: 06 4990 4953 / 4954 Fax: 06 4990 4975 E-mail:
More informationPlasma The Patients Perspective. Brian O Mahony, PLUS (Plasma Users) FIODS Conference, San Marino June 2012
Plasma The Patients Perspective Brian O Mahony, PLUS (Plasma Users) FIODS Conference, San Marino June 2012 1 PLUS (Plasma Users) 2 2 Conditions treated with PDMP s Haemophilia A and B Von Willebrands Disease
More informationdonors and collecting blood and plasma in for-profit or a not for profit environment
Remunerated versus non-remunerated donors and collecting blood and plasma in for-profit or a not for profit environment ISBT Amsterdam, June 4, 2013 Jan M. Bult President PPTA PATIENT CENTEREDNESS IT
More information2014/LSIF/PD/008 Building Blocks and Challenges to Implementing a National Blood Program in Malaysia
2014/LSIF/PD/008 Building Blocks and Challenges to Implementing a National Blood Program in Malaysia Submitted by: Malaysia Policy Dialogue and Workshop on Attaining a Safe and Sustainable Blood Supply
More informationThe establishment of well-organized, nationally-coordinated blood transfusion services with quality systems in all areas
Blood Safety Global Database on Blood Safety (GDBS) 2013 The World Health Organization (WHO) programme on Blood Transfusion Safety would appreciate your kind cooperation in completing this data collection
More informationPresentation of Istituto Superiore di Sanità, Rome, Italy
Presentation of Istituto Superiore di Sanità, Rome, Italy Health Literacy and Health Education Graz, November 24, 2011 Maurella Della Seta, Documentation Service, ISS maurella.dellaseta@iss.it Istituto
More informationBotswana Private Sector Health Assessment Scope of Work
Example of a Scope of Work (Botswana) Botswana Private Sector Health Assessment Scope of Work I. BACKGROUND The Republic of Botswana is a stable, democratic country in Southern Africa with an estimated
More informationPOSITION PAPER PALLIATIVE CARE, PEDIATRIC PALLIATIVE CARE AND PAIN THERAPY: HUMANIZATION OF CARE
POSITION PAPER 1 PALLIATIVE CARE, PEDIATRIC PALLIATIVE CARE AND PAIN THERAPY: HUMANIZATION OF CARE GROUP LEADER: Basilicata Region OTHER PARTNERS: Calabria; Campania; Lazio; Marche; Piemonte; Prov. Aut.
More informationConversion of Whole Blood Donors to Plasma Pheresis Donors
Conversion of Whole Blood Donors to Plasma Pheresis Donors IPFA 2 nd Asia Workshop on Plasma Quality and Supply Jonathan A. Hughes, M.D. Medical Director BloodSource, USA About BloodSource California,
More informationReporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey
Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey This questionnaire consists of three sections: A. Collection and
More informationPlasma Fractionation Issues for Developing Countries DR YASMIN AYOB
Plasma Fractionation Issues for Developing Countries DR YASMIN AYOB Plasma Fractionation Evolved from a medical service to a global manufacturing industry Involves sophisticated industrial process High
More informationStatement from International Transfusion Medicines Experts
Statement from International Transfusion Medicines Experts Application for the Placement of Whole Blood (WB) and Red Blood Cells (RBCs) on the WHO Model Essential Medicines Lists (EML) Open Session of
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES. COMMISSION STAFF WORKING DOCUMENT on Joint procurement of vaccine against influenza A(H1N1)
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 15.9.2009 SEC(2009) 1188 final COMMISSION STAFF WORKING DOCUMENT on Joint procurement of vaccine against influenza A(H1N1) Accompanying document to the
More informationrare diseases research through National Plans and Strategies
Recommendations to support rare diseases research through National Plans and Strategies Dr Domenica Taruscio EUROPLAN Coordinator Director of the Italian Centre for Rare Diseases, Italian National Institute
More informationTGA regulation of local manufacturers of plasma derivatives CSL Behring Australia s overview
IPFA Workshop Session 7: REGULATORY CONSIDERATIONS TGA regulation of local manufacturers of plasma derivatives CSL Behring Australia s overview Mary Lavithis, CSL Behring Australia Presented at: IPFA Asia
More informationOverview of Blood Transfusion System of Iran:
Report Article Overview of Blood Transfusion System of Iran: 2002-2011 AM Cheraghali High Institute for Research and Education on Transfusion Medicine, Iran Blood Transfusion Organization and University
More informationHaemovigilance in Europe: What do health authorities expect from haemovigilance?
Haemovigilance in Europe: What do health authorities expect from haemovigilance? Deirdre Fehily Substances of Human Origin Team Directorate General for and Food Safety Unit B4 Products: quality, safety
More informationPGEU GPUE. Pharmaceutical Group of European Union Groupement Pharmaceutique de l Union Européenne
Public consultation on Delegated Act on Post-Authorisation efficacy studies PGEU RESPONSE INTRODUCTION The Pharmaceutical Group of the European Union (PGEU) is the association representing community pharmacists
More informationMale Circumcision in Zambia: National Operational Plan for Scale-up
Male Circumcision in Zambia: National Operational Plan for Scale-up PEPFAR/WHO/UNAIDS Consultative Meeting Johannesburg, September 28 th, 2012 Dr. Daniel Makawa, National MC Coordinator Background Zambia
More informationTransfusion Medicine in Saudi Arabia
Transfusion Medicine in audi Arabia, Mc, FRCPath, CTM Director of Blood Transfusion ervices Associate Professor in Haematology KAUH, Jeddah, audi Arabia Total Area1,960,582.00 sq Population27,019,731 (2006
More informationCouncil of the European Union Brussels, 28 October 2015 (OR. en)
Conseil UE Council of the European Union Brussels, 28 October 2015 (OR. en) PUBLIC 13261/15 LIMITE SAN 347 NOTE From: To: Subject: General Secretariat of the Council Working Party on Public Health Draft
More information2016 FP2020 ANNUAL COMMITMENT UPDATE QUESTIONNAIRE RESPONSE
MYANMAR HTTP://WWW.FAMILYPLANNING2020.ORG/MYANMAR In July 2016, the government of Myanmar shared the following update on progress toward achieving its Family Planning 2020 commitment during the 2015-2016
More informationCompetent Authorities on Substances of Human Origin Expert Group (CASoHO E01718) Meeting of the Competent Authorities on Blood and Blood Components
Ref. Ares(2015)3569906-31/08/2015 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Directorate D - Health systems and products D4 Substances of Human Origin and Tobacco Control Competent
More informationStrengthening Health Systems and Blood Services
Strengthening Health Systems and Blood Services through a Primary Health Care Approach Dr Neelam Dhingra Coordinator Blood Transfusion safety WHO-HQ, Geneva Outline of the Presentation Blood Transfusion
More informationMEDICAL DEVICES. Aurora. Improved efficiency, outstanding donation experience
MEDICAL DEVICES Aurora Plasmapheresis System Improved efficiency, outstanding donation experience Aurora Plasmapheresis System Improved efficiency, outstanding donation experience The Aurora Plasmapheresis
More informationManagement of notifications of donors with Creutzfeldt-Jakob disease (post-donation information) SIMTI Servizi Srl
P P Management of notifications of donors with Creutzfeldt-Jakob disease (post-donation information) Gabriele Calizzani 1*, Stefania Vaglio 1*, Vito Vetrugno 2, Marisa Delbò 3, Luca Pani 3, Giuliano Grazzini
More information1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.
Council of the European Union Brussels, 26 November 2015 (OR. en) 14395/15 SAN 391 NOTE From: To: Subject: General Secretariat of the Council Permanent Representatives Committee/Council Employment, Social
More informationSlide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes
Slide 1 International Operations update Mike Doustdar EVP International Operations YASMIN FIEDLER, Germany Yasmin has type 1 diabetes Slide 2 Forward-looking statements Novo Nordisk s reports filed with
More informationFalsified Medicines Directive (FMD) Dispensing Doctors Association Wednesday 18-Oct-17 Jerome Bertin
Falsified Medicines Directive (FMD) Dispensing Doctors Association Wednesday 18-Oct-17 Jerome Bertin Objectives What is FMD all about and when does it need to happen? Who are SecurMed and what is our role
More informationWCO ACTION PLAN FOR THE ECONOMIC COMPETITIVENESS PACKAGE
WCO ACTION PLAN FOR THE ECONOMIC COMPETITIVENESS PACKAGE Overview The Economic Competitiveness Package (ECP) was endorsed at the 119 th /120 th Sessions of the WCO Council, with three core goals : (1)
More informationCABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND
CABINET Report No: 105/2017 PUBLIC REPORT 16 May 2017 PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND Report of the Director of Public Health Strategic Aim: Safeguarding Key Decision:
More informationReport by the Comptroller and. SesSIon January Improving Dementia Services in England an Interim Report
Report by the Comptroller and Auditor General HC 82 SesSIon 2009 2010 14 January 2010 Improving Dementia Services in England an Interim Report 4 Summary Improving Dementia Services in England an Interim
More informationMeeting Report Consultation between WHO Secretariat and the Secretariat of the CBD March 2017 Montreal, Canada
Meeting Report Consultation between WHO Secretariat and the Secretariat of the CBD 20-21 March 2017 Montreal, Canada Background 1. The Executive Board at its 140th session in January 2017 considered the
More informationHUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE. Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, May, 2012.
HUNGARIAN NATIONAL BLOOD TRANSFUSION SERVICE Dr. Klara Baroti-Tóth, PhD IPFA/PEI 19 th International Workshop Budapest, 23-24 May, 212. BLOOD DONATION G I V I N G I S G O O D ORGAN COORDINATION OFFICE
More informationFit4RareFit4All Conference Cluj - Napoca 3-4 September 2017
Fit4RareFit4All Conference Cluj - Napoca 3-4 September 2017 Rare diseases registries as key tools in research and public health Domenica Taruscio Director, National Centre for Rare Diseases Istituto Superiore
More informationREPORT CARD on Canada s Blood System
2005-2007 REPORT CRD on Canada s Blood System Ten Years after the Commission of Inquiry on the Blood System in Canada Prepared by the Blood Safety and Supply Committee of the Canadian Hemophilia Society
More information- Description, Objectives, Operational Framework
2 1. CNCD - Overview (significance, causes, burden) 2. CDAP - Description, Objectives, Operational Framework 3. Research Findings of Study on CDAP - Research Objectives and Methodology - Limitations and
More informationResolution. REGIONAL COMMITTEE FOR THE EASTERN MEDITERRANEAN October 2009
WORLD HEALTH ORGANIZATION ORGANISATION MONDIALE DE LA SANTE Resolution REGIONAL COMMITTEE FOR THE EM/RC56/R.5 EASTERN MEDITERRANEAN October 2009 Fifty-sixth Session Agenda item 6 (a) The growing threats
More informationState of provision of Hearing Aids in Europe
Creating a barrier-free Europe for all hard of hearing citizens State of provision of Hearing Aids in Europe 2018 Report 1 Executive Summary Dear Reader, We are pleased to share the report examining affordability
More informationEssential Medicines. WHO
12 Health Technology and Pharmaceuticals Participants to the Workshop on Pharmaceutical Policies and Access to Good Quality Essential Medicines for Pacific Island Countries observing pharmaceutical services
More informationIl ruolo delle VEQ per la sicurezza trasfusionale
Il ruolo delle VEQ per la sicurezza trasfusionale The role of EQA for transfusion safety Giulio Pisani CNCF Ist. Sup. Sanità Global Blood Product Safety, Roma 10 aprile 2019 Blood transfusion is an essential
More informationThe Global Picture in Blood Transfusions: A Quick Overview
The Global Picture in Blood Transfusions: A Quick Overview Jim MacPherson President & CEO MacPherson Strategies jim@macphersonstrategies.com +1 202 468 6548 24 March 2017 WHO 2016 Of the 113 million blood
More informationPlasma for fractionation: South African Plasma Requirements
Plasma for fractionation: South African Plasma Requirements Dr Jeh-han Omarjee Head: Microbiological Sciences NBI is a "not for profit" company committed to providing safe, cost effective, quality medicinal
More informationPOLICY ANALYST JOB DESCRIPTION
POLICY ANALYST JOB DESCRIPTION August 2010 Location: Hours of Work: Responsible to: National Office, Auckland 30 hours per week Executive Director The NZAF has an expectation that all staff will: Demonstrate
More informationDesigning publicly funded healthcare markets Note by the Russian Federation
Organisation for Economic Co-operation and Development DAF/COMP/WP2/WD(2018)42 DIRECTORATE FOR FINANCIAL AND ENTERPRISE AFFAIRS COMPETITION COMMITTEE English - Or. English 5 November 2018 Working Party
More information39th SESSION OF THE SUBCOMMITTEE ON PLANNING AND PROGRAMMING OF THE EXECUTIVE COMMITTEE
PAN AMERICAN HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION 39th SESSION OF THE SUBCOMMITTEE ON PLANNING AND PROGRAMMING OF THE EXECUTIVE COMMITTEE Washington, D.C., USA, 16-18 March 2005 Provisional Agenda
More informationStrengthening our global leadership in treatment of addiction. Morgan Stanley Global Healthcare Conference September 13 th and 14 th 2018
Strengthening our global leadership in treatment of addiction Morgan Stanley Global Healthcare Conference September 13 th and 14 th 2018 Forward Looking Statements This presentation contains certain statements
More informationINFECTED BLOOD INQUIRY TERMS OF REFERENCE
INFECTED BLOOD INQUIRY TERMS OF REFERENCE What happened and why? 1. To examine the circumstances in which men, women and children 1 treated by national Health Services in the United Kingdom (collectively,
More informationGlobal call for action to ensure universal access to malaria diagnosis and treatment
Global call for action to ensure universal access to malaria diagnosis and treatment Joint activity of SEE Team and PDT Unit Andrea Bosman and Richard Cibulskis Outline of the presentation Background Objectives
More informationEurydice activities in the field of Early Childhood Education and Care (KD ECEC 2014)
Eurydice activities in the field of Early Childhood Education and Care (KD ECEC 2014) Daniela Kocanova Education, Audiovisual and Culture Executive Agency (EACEA), Eurydice 12 th meeting of the OECD Network
More informationThe Prime Minister s Challenge on Dementia Lorraine Jackson Deputy Director: Dementia Policy Department of Health 12 April 2016
The Prime Minister s Challenge on Dementia 2020 1 Lorraine Jackson Deputy Director: Dementia Policy Department of Health 12 April 2016 Costs and impact of dementia Estimated 676,000 people in England with
More informationQSEAL Recovered Plasma Specification
QSEAL Recovered Plasma Specification Background The is part of a series of standards that comprise the Plasma Protein Therapeutics Association (PPTA) QSEAL Standards Program. PPTA's Voluntary Standards
More informationThe Cigarette Market in Greece
The Cigarette Market in Greece Product Code: CG0145MR Published Date: April 2015 Report Price: US$ 975 (Single Copy) Synopsis Cigarettes in Greece report is a qualitative report providing extensive and
More informationFondazione Banco Alimentare Onlus Via Legnone 4 _ Milano _ T _ F _ E _ CF
June 2014 Position statement of the Fondazione Banco Alimentare Onlus The Fondazione Banco Alimentare Onlus (hereinafter, FBAO ), through its network of 21 Food Banks in Italy, is committed to fight against
More informationNew Advances in Transfusion EM I LY CO BERLY, M D
New Advances in Transfusion EM I LY CO BERLY, M D TRANSFUSI ON M EDI CI NE FELLO W VANDERBI LT UNI VERSITY Objectives To discuss the terminology, components, transfusion risks, and dosing guidelines for
More informationORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies
ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies ISSUING BODY: The Ministry of Health published in: the Official
More informationSlide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A
Slide 1 Financial update and closing remarks Jesper Brandgaard EVP and CFO RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A Slide 2 Forward-looking statements Novo Nordisk s reports filed with or
More informationTherapeutic Apheresis Services Annual Review 2016/17
Therapeutic Apheresis Services Annual Review 2016/17 NHS Blood and Transplant (NHSBT) is a major provider of Therapeutic Apheresis Services (TAS) in the NHS. Services are provided across England. Collection
More informationDavid Zaccardelli, PharmD Chief Executive Officer. J.P. Morgan 37 th Annual Healthcare Conference January 8, 2019
David Zaccardelli, PharmD Chief Executive Officer J.P. Morgan 37 th Annual Healthcare Conference January 8, 2019 Disclaimer Certain information contained in this presentation relates to or is based on
More informationPROGRAMME INITIATION DOCUMENT MENTAL HEALTH PROGRAMME
PROGRAMME INITIATION DOCUMENT MENTAL HEALTH PROGRAMME 1. BACKGROUND: 1.1 Primary Care 90% of mental health care is provided within primary care services, with the most common mental health problems identified
More informationPharmaceutical System in the UK
Pharmaceutical System in the UK David Kullman Medicines, i Pharmacy and Industry Group Department of Health PPRI Conference, Vienna 30 September 2011 Disclaimer Conflict of interest: Nothing to disclose
More informationStrategy Strategic delivery: Setting standards Increasing and informing choice. Details: Output: Demonstrating efficiency economy and value
Strategy 2017-20 Strategic delivery: Setting standards Increasing and informing choice Demonstrating efficiency economy and value Details: Meeting Authority Agenda item 7 Paper number HFEA (11/05/2016)
More informationA Snapshot on Italian Dentistry, Have Italians Given Up the Dentist? Author: Silvia Borriello Population 60.7.
A Snapshot on Italian Dentistry, Have Italians Given Up the Dentist? Author: Silvia Borriello silvia.borriello@infodent.com Italian dentistry today is completely different from what it was 25 years ago
More informationProcurement update: StopTB Partnership - Global Drug Facility (GDF)
Procurement update: StopTB Partnership - Global Drug Facility (GDF) Magali BABALEY Strategic Procurement and Business Intelligence Manager Stop TB Partnership, Global Drug Facility (GDF) team joint UNICEF-UNFPA-WHO
More informationGuide to the preparation, use and quality assurance of blood components
Contents Foreword...3 Members of the European Committee (Partial Agreement) on Blood Transfusion... 8 Members of the GTS working group... 22 Members of the TS066 working group... 30 Recommendation No.
More information2018/ /21 SERVICE PLAN
2018/19 2020/21 SERVICE PLAN February 2018 For more information on the Legal Services Society contact: 400 510 Burrard Street Vancouver, BC V5C 3A8 604-601-6000 Or visit our website at legalaid.bc.ca Board
More informationChronic Non Communicable Disease. The Grenada Experience.
Chronic Non Communicable Disease The Grenada Experience. Core Values Government of Grenada views health A basic human right A vehicle for economic growth and social development. Emphasis Primary prevention
More informationPresentation to 13th Annual General Meeting of the DCVMN UNICEF Vaccine Forecasting
Presentation to 13th Annual General Meeting of the DCVMN UNICEF Vaccine Forecasting 1 November 2012 Deaths among children under 5 globally; 19,000 die every day from preventable causes 18% 1% 2% 2% 5%
More informationDevelopment Bank of Southern Africa Amendment Bill [B ]
Development Bank of Southern Africa Amendment Bill [B 2-2014] Briefing of Standing Committee on Finance National Assembly 8 July 2014 Presenters: Mr Lefentse Radikeledi Director: Asset and Liability Management
More informationEuropean actions in the field of transplantation & blood transfusion
European actions in the field of transplantation & blood transfusion Andrzej Rys Director Directorate Health Systems and Products Madrid, 27 June 2013 1 Blood Tissues and cells Organs 2 Blood transfusion
More informationRepresenting Homeopaths in Europe
The European Council for Classical Homeopathy School House, Market Place, Kenninghall, Norfolk NR16 2AH United Kingdom Telephone & Fax: (44) 1953 888163 http://www.homeopathy-ecch.org Email: ecch@homeopathy-ecch.org
More informationIntensifying our efforts towards a world free of the avoidable burden of NCDs
OUTCOME DOCUMENT OF THE HIGH-LEVEL MEETING OF THE GENERAL ASSEMBLY ON THE REVIEW OF THE PROGRESS ACHIEVED IN THE PREVENTION AND CONTROL OF NON- COMMUNICABLE DISEASES Revised version dated 3 July 2014 11.50
More informationBrain research supported by the European Union
Brain research supported by the European Union Lara Passante, PhD Health Directorate Directorate-General for Research & European Commission FENS Featured Regional Meeting 11-14 Septembre 2013 Prague Neuroscience:
More informationStructure and duties of Blood service
NATIONAL CENTER FOR TRANSFUSION MEDICINE Prevalence of infectious diseases among Mongolian blood donors Namjil Erdenebayar General director of The National Center for Transfusion Medicine, Mongolia NCTM,
More informationInducing Tumor-Specific Ischemic Necrosis to Enhance the Efficacy of Checkpoint Inhibitors and Chemotherapy
Inducing Tumor-Specific Ischemic Necrosis to Enhance the Efficacy of Checkpoint Inhibitors and Chemotherapy Company Overview, September 2018 Safe Harbor Statement This presentation contains forward-looking
More informationNAMIBIA INVESTMENT CASE
NAMIBIA INVESTMENT CASE OUTLINE Why an Investment Case for HIV Response in Namibia? Investment Scenarios Can we achieve Fast Track and End AIDS as public health threat by 2030? Can we afford it? Efficiencies:
More informationDraft resolution submitted by the President of the General Assembly
United Nations A/68/L.53 General Assembly Distr.: Limited 7 July 2014 Original: English Sixty-eighth session Agenda item 118 Follow-up to the outcome of the Millennium Summit Draft resolution submitted
More informationEpilepsy Foundation North/ Central Illinois. FY19-FY21 3 year Strategic Plan 20 June 2018
Epilepsy Foundation North/ Central Illinois FY19-FY21 3 year Strategic Plan 20 June 2018 Strategic Plan Overview The reason we exist is to bring hope where there is none Help connect people with resources
More informationAnalgesics for the treatment of pain in Italy
Societal Impact of Pain Brussels 3-4 May 2011 Analgesics for the treatment of pain in Italy Giovanni Tafuri, PharmD Pharmaceutical Policy Unit - Italian Medicines Agency (AIFA) Legislation milestones of
More informationObjectives. Methods. Results. Economic
Octaplas Compared with Fresh Frozen Plasma to Reduce the Risk of Transmitting Lipid-Enveloped Viruses: An Economic Analysis and Budget Impact Analysis [Adapted from Membe SK, Coyle D, Husereau D, Cimon
More informationOverview of comments received on 'Guideline on the clinical investigation of hepatitis B immunoglobulins' (EMA/CHMP/BPWP/585257/2009)
23 July 2015 EMA/CHMP/BPWP/356886/2013 Committee for Medicinal Products for Human Use (CHMP) Overview of comments received on 'Guideline on the clinical investigation of hepatitis B immunoglobulins' (EMA/CHMP/BPWP/585257/2009)
More informationMonitoring the Declaration of Commitment on HIV/AIDS & UNGASS indicators
Monitoring the Declaration of Commitment on HIV/AIDS & UNGASS indicators José Antonio Izazola Chief, AIDS Financing and Economics Division Evidence, Monitoring and Policy Department UNAIDS Assessment 6.3
More informationAnnual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, András Tövisi Chairman of the Board of Directors
Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, 2014 András Tövisi Chairman of the Board of Directors Philip Morris ČR a.s. Annual General Meeting of Shareholders 2014
More informationAlcohol and Drug Commissioning Framework for Northern Ireland Consultation Questionnaire.
Alcohol and Drug Commissioning Framework for Northern Ireland 2013-16 Consultation Questionnaire. This questionnaire has been designed to help stakeholders respond to the above framework. Written responses
More informationIl Patient Blood Management in Italia. Dr. Giancarlo Maria Liumbruno Direttore Generale, Centro Nazionale Sangue Istituto Superiore di Sanità, Roma
Il Patient Blood Management in Italia Dr. Giancarlo Maria Liumbruno Direttore Generale, Centro Nazionale Sangue Istituto Superiore di Sanità, Roma Aggiornamenti in Medicina Trasfusionale - Enna, 4 ottobre
More informationExecutive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services
United Nations Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services Distr.: General 25 April 2014 Original:
More informationMini Pool Plasma Fractionation: A Pragmatic Approach to Fill in Gaps of Supply and Access
Mini Pool Plasma Fractionation: A Pragmatic Approach to Fill in Gaps of Supply and Access Magdy El Ekiaby, MD Egypt 7th Annual Bioplasma World Asia 2018 12 to 13 September 2018 Singapore Global FVIII
More informationManagement Response. Canadian Blood Services Response to Questions from the Canadian Hemophilia Society
Canadian Blood Services to Questions from the Canadian Hemophilia Society Introduction On Nov. 26, 1997, the final report of the Royal Commission of Inquiry on the in Canada was tabled in the House of
More informationVaccine shortages: Improving cooperation, communication and management Michael Sulzner
Vaccine shortages: Improving cooperation, communication and management Michael Sulzner Public Health Directorate DG Health & Food Safety 13 April 2016, Geneva Decision 1082/2013/EU on serious cross-border
More informationMinister s Declaration
Explanatory Memorandum (including Regulatory Impact Assessment) to accompany the National Health Service (Dental Charges) (Wales) (Amendment) Regulations 2015 This Explanatory Memorandum has been prepared
More information34 th Annual J.P. Morgan Healthcare Conference
JANUARY 2016 34 th Annual J.P. Morgan Healthcare Conference [ 1 ] Forward Looking Statements SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS In addition to historical information, this presentation contains
More informationOral semaglutide and production expansion. Henrik Wulff EVP Product Supply. Peter Kristensen SVP Global Development
YASMIN FIEDLER Germany Yasmin has type 1 diabetes Slide 1 Oral semaglutide and production expansion Henrik Wulff EVP Product Supply Peter Kristensen SVP Global Development Slide 2 Forward-looking statements
More informationNATIONAL BLOOD TRANSFUSION SERVICES STRATEGY
FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA MINISTRY OF HEALTH NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY February 2005 Addis Ababa Ethiopia Acknowledgement The Ministry of Health of the Federal Democratic
More informationCorporate Overview. beyond pioneering
Corporate Overview beyond pioneering Who We Are Bruining Erkelens DROge (= dry ) CANnabis 1 st 5 Standardized Cultivars 18 Jurisdictions served Five (5) unique cultivars have been standardized and commercially
More information